377 related articles for article (PubMed ID: 33092644)
21. LncRNA EGFR-AS1 Upregulates ROCK1 by Sponging miR-145 to Promote Esophageal Squamous Cell Carcinoma Cell Invasion and Migration.
Feng Z; Li X; Qiu M; Luo R; Lin J; Liu B
Cancer Biother Radiopharm; 2020 Feb; 35(1):66-71. PubMed ID: 31702393
[No Abstract] [Full Text] [Related]
22. LncRNA CDKN2B-AS1 promotes the progression of ovarian cancer by miR-143-3p/SMAD3 axis and predicts a poor prognosis.
Xu C; Zhai J; Fu Y
Neoplasma; 2020 Jul; 67(4):782-793. PubMed ID: 32305052
[TBL] [Abstract][Full Text] [Related]
23. Long non-coding RNA OIP5-AS1 functions as an oncogene in lung adenocarcinoma through targeting miR-448/Bcl-2.
Deng J; Deng H; Liu C; Liang Y; Wang S
Biomed Pharmacother; 2018 Feb; 98():102-110. PubMed ID: 29247949
[TBL] [Abstract][Full Text] [Related]
24. Effects of long non-coding RNA Opa-interacting protein 5 antisense RNA 1 on colon cancer cell resistance to oxaliplatin and its regulation of microRNA-137.
Liang J; Tian XF; Yang W
World J Gastroenterol; 2020 Apr; 26(13):1474-1489. PubMed ID: 32308348
[TBL] [Abstract][Full Text] [Related]
25. LncRNA MNX1-AS1 promotes ovarian cancer process via targeting the miR-744-5p/SOX12 axis.
Shen Y; Lv M; Fang Y; Lu J; Wu Y
J Ovarian Res; 2021 Nov; 14(1):161. PubMed ID: 34789303
[TBL] [Abstract][Full Text] [Related]
26. LncRNA FGD5-AS1 promotes tumor growth by regulating MCL1 via sponging miR-153-3p in oral cancer.
Ge C; Dong J; Chu Y; Cao S; Zhang J; Wei J
Aging (Albany NY); 2020 Jul; 12(14):14355-14364. PubMed ID: 32675387
[TBL] [Abstract][Full Text] [Related]
27. Long non-coding RNA AFAP1-AS1 facilitates ovarian cancer progression by regulating the miR-107/PDK4 axis.
Liu B; Yan L; Chi Y; Sun Y; Yang X
J Ovarian Res; 2021 Apr; 14(1):60. PubMed ID: 33926489
[TBL] [Abstract][Full Text] [Related]
28. LncRNA HOXD-AS1 promotes oral squamous cell carcinoma by sponging miR-203a-5p.
Zhang Y; Wang F; Yu Y
Oral Dis; 2023 May; 29(4):1505-1512. PubMed ID: 35152529
[TBL] [Abstract][Full Text] [Related]
29. The Long Non-Coding RNA (lncRNA) AGAP2-AS1 is Upregulated in Ovarian Carcinoma and Negatively Regulates lncRNA MEG3.
Chen J; Peng X; Dai Y
Med Sci Monit; 2019 Jun; 25():4699-4704. PubMed ID: 31233485
[TBL] [Abstract][Full Text] [Related]
30. LncRNA FGD5-AS1 promotes the malignant phenotypes of ovarian cancer cells via targeting miR-142-5p.
Aichen Z; Kun W; Xiaochun S; Lingling T
Apoptosis; 2021 Jun; 26(5-6):348-360. PubMed ID: 33974163
[TBL] [Abstract][Full Text] [Related]
31. OIP5-AS1 promotes the progression of gastric cancer cells via the miR-153-3p/ZBTB2 axis.
Zhi XH; Jiang K; Ma YY; Zhou LQ
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2428-2441. PubMed ID: 32196594
[TBL] [Abstract][Full Text] [Related]
32. Long non-coding RNA OIP5-AS1 serves as a competing endogenous RNA to modulate X-linked inhibitor of apoptosis protein expression via adsorbing miR-429 in papillary thyroid cancer.
Yu CS; Wang YB; Li Q; Yang EL; Dong BB
J Biol Regul Homeost Agents; 2021; 35(3):909-920. PubMed ID: 34155880
[TBL] [Abstract][Full Text] [Related]
33. LncRNA miR503HG interacts with miR-31-5p through multiple ways to regulate cancer cell invasion and migration in ovarian cancer.
Zhu D; Huang X; Liang F; Zhao L
J Ovarian Res; 2020 Jan; 13(1):3. PubMed ID: 31907059
[TBL] [Abstract][Full Text] [Related]
34. Long non-coding RNA TP73-AS1 sponges miR-194 to promote colorectal cancer cell proliferation, migration and invasion via up-regulating TGFα.
Cai Y; Yan P; Zhang G; Yang W; Wang H; Cheng X
Cancer Biomark; 2018; 23(1):145-156. PubMed ID: 30010111
[TBL] [Abstract][Full Text] [Related]
35. LncRNA MNX1-AS1 promotes progression of esophageal squamous cell carcinoma by regulating miR-34a/SIRT1 axis.
Chu J; Li H; Xing Y; Jia J; Sheng J; Yang L; Sun K; Qu Y; Zhang Y; Yin H; Wan J; He F
Biomed Pharmacother; 2019 Aug; 116():109029. PubMed ID: 31170665
[TBL] [Abstract][Full Text] [Related]
36. A novel lncRNA, Lnc-OC1, promotes ovarian cancer cell proliferation and migration by sponging miR-34a and miR-34c.
Tao F; Tian X; Lu M; Zhang Z
J Genet Genomics; 2018 Mar; 45(3):137-145. PubMed ID: 29576507
[TBL] [Abstract][Full Text] [Related]
37. LncRNA OIP5-AS1 Promotes Breast Cancer Progression by Regulating miR-216a-5p/GLO1.
Wu Z; Liu Y; Wei L; Han M
J Surg Res; 2021 Jan; 257():501-510. PubMed ID: 32916503
[TBL] [Abstract][Full Text] [Related]
38. LncRNA OIP5-AS1 is overexpressed in undifferentiated oral tumors and integrated analysis identifies as a downstream effector of stemness-associated transcription factors.
Arunkumar G; Anand S; Raksha P; Dhamodharan S; Prasanna Srinivasa Rao H; Subbiah S; Murugan AK; Munirajan AK
Sci Rep; 2018 May; 8(1):7018. PubMed ID: 29728583
[TBL] [Abstract][Full Text] [Related]
39. Long noncoding RNA OIP5-AS1 accelerates CDK14 expression to promote osteosarcoma tumorigenesis via targeting miR-223.
Dai J; Xu L; Hu X; Han G; Jiang H; Sun H; Zhu G; Tang X
Biomed Pharmacother; 2018 Oct; 106():1441-1447. PubMed ID: 30119217
[TBL] [Abstract][Full Text] [Related]
40. Downregulation of LncRNA OIP5-AS1 Induced by IL-1β Aggravates Osteoarthritis via Regulating miR-29b-3p/PGRN.
Zhi L; Zhao J; Zhao H; Qing Z; Liu H; Ma J
Cartilage; 2021 Dec; 13(2_suppl):1345S-1355S. PubMed ID: 32037864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
